William Blair downgraded Incyte (INCY) to Market Perform from Outperform.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY:
- Incyte downgraded to Neutral from Buy at Guggenheim
- Incyte’s Promising Phase 3 Results and Market Potential Drive Buy Rating
- Leerink says Incyte’s povo trial results disappoint, drug likely to be approved
- PepsiCo to acquire poppi, Guess receives WHP offer: Morning Buzz
- Incyte stock decline after results an ‘overreaction,” says Wolfe Research